Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-05
2011-04-05
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S415000, C546S112000, C548S469000
Reexamination Certificate
active
07919503
ABSTRACT:
The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
REFERENCES:
patent: 2006/0160879 (2006-07-01), Olofsson et al.
Affectis Pharmaceuticals AG
Anderson Rebecca L
Cooley LLP
Shterengarts Samantha L
LandOfFree
P2X7R antagonists and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P2X7R antagonists and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P2X7R antagonists and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2631659